| Literature DB >> 34024488 |
Katherine C Wai1, Hyunseok Kang2, Patrick K Ha3.
Abstract
Despite aggressive initial interventions, recurrent/metastatic salivary gland cancer is not uncommon. Standard chemotherapy has not been shown to have durable clinical benefits. Several potential molecular markers have been identified in different histologic subtypes of salivary cancers. The objective of this review is to highlight the molecular markers that have been targeted in clinical trials for salivary gland cancers.Entities:
Keywords: Molecular markers; Salivary gland cancer; Targeted therapy
Year: 2021 PMID: 34024488 DOI: 10.1016/j.otc.2021.01.007
Source DB: PubMed Journal: Otolaryngol Clin North Am ISSN: 0030-6665 Impact factor: 3.346